全文获取类型
收费全文 | 16271篇 |
免费 | 1359篇 |
国内免费 | 71篇 |
专业分类
耳鼻咽喉 | 251篇 |
儿科学 | 384篇 |
妇产科学 | 559篇 |
基础医学 | 1666篇 |
口腔科学 | 295篇 |
临床医学 | 1750篇 |
内科学 | 3232篇 |
皮肤病学 | 278篇 |
神经病学 | 1545篇 |
特种医学 | 706篇 |
外国民族医学 | 2篇 |
外科学 | 2219篇 |
综合类 | 275篇 |
一般理论 | 14篇 |
预防医学 | 1709篇 |
眼科学 | 402篇 |
药学 | 1143篇 |
中国医学 | 13篇 |
肿瘤学 | 1258篇 |
出版年
2022年 | 120篇 |
2021年 | 242篇 |
2020年 | 170篇 |
2019年 | 271篇 |
2018年 | 288篇 |
2017年 | 246篇 |
2016年 | 301篇 |
2015年 | 317篇 |
2014年 | 424篇 |
2013年 | 612篇 |
2012年 | 894篇 |
2011年 | 930篇 |
2010年 | 505篇 |
2009年 | 449篇 |
2008年 | 794篇 |
2007年 | 913篇 |
2006年 | 926篇 |
2005年 | 934篇 |
2004年 | 865篇 |
2003年 | 812篇 |
2002年 | 741篇 |
2001年 | 359篇 |
2000年 | 388篇 |
1999年 | 385篇 |
1998年 | 200篇 |
1997年 | 171篇 |
1996年 | 148篇 |
1995年 | 126篇 |
1994年 | 111篇 |
1993年 | 118篇 |
1992年 | 250篇 |
1991年 | 242篇 |
1990年 | 246篇 |
1989年 | 211篇 |
1988年 | 198篇 |
1987年 | 194篇 |
1986年 | 217篇 |
1985年 | 214篇 |
1984年 | 154篇 |
1983年 | 149篇 |
1982年 | 108篇 |
1981年 | 99篇 |
1979年 | 162篇 |
1978年 | 111篇 |
1977年 | 113篇 |
1976年 | 97篇 |
1975年 | 110篇 |
1974年 | 131篇 |
1973年 | 109篇 |
1972年 | 98篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Christian Holm Hansen Shelley Lees Saidi Kapiga Janet Seeley Tony Barnett 《Global public health》2020,15(3):402-413
ABSTRACTMeasuring hope reliably and accurately remains an important research objective, not least in less prosperous settings where ‘holding on to hope’ may be critically important in the struggle against adverse life conditions. The State Hope Scale was designed for use in the US. Despite reported application in diverse cultures and using translations the scale has not been extensively validated outside US populations. This study contributes to a larger project exploring the measurement of hope and provides a critique of Snyder’s scale as used in a Tanzanian female population of 1021 urban microfinance participants. We evaluate the scale’s validity through assessment of the empirical distribution of scores, item response profiles, internal consistency and discriminatory ability. Participants mostly scored very high and many reached very near the maximum attainable score. Hardly any endorsed the negative half of the response scale. Several problems are discussed including poor discrimination and strong evidence of acquiescence response bias. We also found little association of the scale scores with hypothesised correlates of hope. Future improvements on the measurement of hope are recommended, especially in studies outside the narrow Western context in which the scale was devised. 相似文献
2.
3.
4.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献5.
Toshiro Hara Rony Chanoch-Myers Nathan D. Mathewson Chad Myskiw Lyla Atta Lillian Bussema Stephen W. Eichhorn Alissa C. Greenwald Gabriela S. Kinker Christopher Rodman L. Nicolas Gonzalez Castro Hiroaki Wakimoto Orit Rozenblatt-Rosen Xiaowei Zhuang Jean Fan Tony Hunter Inder M. Verma Kai W. Wucherpfennig Itay Tirosh 《Cancer cell》2021,39(6):779-792.e11
- Download : Download high-res image (228KB)
- Download : Download full-size image
6.
7.
8.
9.
Andreas Karatsaidis Olav Schreurs Kristen Helgeland Tony Axéll Karl Schenck 《Journal of oral pathology & medicine》2003,32(5):275-281
BACKGROUND: Common clinical forms of oral lichen planus (OLP) and oral lichenoid reactions (OLR) are erythematous (ERY) or reticular (RET). The purpose of this study was to find histopathological changes that differ between these forms. METHODS: Epithelial thickness, epithelial proliferation rate, apoptosis, and HLA-DR expression were compared among 10 reticular and 12 erythematous lesions, and 11 normal oral mucosa samples (NOM). RESULTS: The epithelium in ERY was thinner than in NOM, whereas RET showed values between ERY and NOM. Cell proliferation increased significantly in ERY as compared with RET and NOM, with no difference between RET and NOM. Relative numbers of epithelial cell nuclei displaying visible chromatin condensation were reduced in ERY form. CONCLUSIONS: The markedly increased cell proliferation in ERY supports the notion that this form displays a higher disease activity as compared to RET. It can therefore be important to study each disease form separately. 相似文献
10.
Tony R Cucuzzella Elva G Delport Nancy Kim Julie Marley Christine Pruitt Anton G Delport 《The spine journal》2006,6(4):364-369
BACKGROUND CONTEXT: Substantial variation exists regarding the use of sedation before interventional spine techniques. Patient preference should play an important role in decision making regarding the need for sedation. However, little is known about patients' anxiety levels before spinal injections and their perceptions about the necessity of sedation. PURPOSE: To determine patient perception for need for sedation before epidural steroid injections and zygapophyseal joint injections. STUDY DESIGN/SETTING: Survey of consecutive spinal injection patients in an outpatient spine center. PATIENT SAMPLE: 500 consecutive lumbar, thoracic, and cervical patients receiving spinal injections. OUTCOME MEASURES: A 12-item questionnaire assessing patients' perceived anxiety before to a spinal injection. METHODS: Subjects were given the questionnaire after their spinal injection. Percentages requesting sedation for a first and potential second procedure were assessed. Additionally, anxiety level and pain rating, location of injection, age, sex, and other medication use were analyzed to determine the effect on the request for sedation. RESULTS: 17% of patients questioned requested sedation before an injection, and 28% would request sedation if they were to have a second injection. CONCLUSIONS: Routine sedation before diagnostic and therapeutic injections is not necessary as the majority of patients would not request sedation before the procedure when given the option. However, in some patients sedation is indicated, and all patients would benefit from educational material on sedation before the injection. 相似文献